SOURCE: PHT Corporation

June 23, 2008 11:41 ET

PHT Expands LogPad eDiary Portfolio With Proven Windows Mobile® Devices by Hewlett-Packard

Leading Electronic Patient Reported Outcome (ePRO) System on HP iPAQ 210 Offers Greater Trial Efficiency, Patient Ease of Use, Lower Cost

BOSTON, MA--(Marketwire - June 23, 2008) - PHT Corporation, the leading provider of ePRO solutions used in more than 350 clinical trials worldwide, today announced the groundbreaking LogPad™ ePRO system is now available on the Windows Mobile platform as well as the Palm® operating system. This further expands PHT's leading portfolio of proven eDiary devices by adding the Hewlett-Packard iPAQ 210, a slim, wireless handheld device with a high-resolution 4" color touch screen.

PHT continues to lead the ePRO market with product and service innovations.

"The LogPad on Windows Mobile reflects our commitment to consistently finding ways to offer sponsors freedom of choice, world-class service, and lower costs per patient," said Phil Lee, PHT President and CEO. "This new platform is the result of our unmatched experience and innovation over 10 years and 350 increasingly complex clinical trials."

PHT chose the cost-effective HP iPAQ 210 after exhaustive device searches and evaluations. It provides PHT customers and users with a range of benefits, including trustworthy SimpleSend™ telecommunication options and the ability to support many fonts and languages in global trials. Additional key benefits:

--  Reduced respondent burden -- As with all PHT devices, the hardware
    never intrudes on clinical data capture. The streamlined pocket-sized iPAQ
    210 features branching logic, reminder alarms, structured response options
    and clear and simple data transmissions.
--  Longevity -- HP is a known and proven technology provider with a
    commitment to enhance and support the iPAQ 210 for years to come.
--  Lower costs -- PHT's innovative business model makes using the LogPad
    on the HP iPAQ 210 the smart business choice for sponsors by reducing
    investment in up-front hardware costs. Details of this exciting program
    will be announced to PHT clients in the coming months.

"PHT is customer focused and our customers are asking for choice -- both in ePRO devices and business models," said Lee. "We are committed to support the needs of our forward-thinking customers both now and in the future. Our addition of the Windows Mobile platform on Hewlett-Packard devices underscores our dedication to enabling good science with reliable and cutting-edge technology."

Visit PHT at DIA Exhibit Booth #1309 for a personalized demonstration.

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 350 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient from homes and sites in 60 countries around the world. By capturing high-quality and time-stamped data, transmitted using reliable SimpleSend™ telecommunications, sponsors are able to run smaller and more conclusive clinical research programs. Meanwhile, real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least 11 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning

PHT, LogPad, eSense, StudySense and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information